PUBLIC COMPANY
save$RDHLRedHill Biopharma Ltd.
$RDHL0.7390+6.64%Tel Aviv, ILupdated 13d ago
community read0 votes
pipeline
5
marketed
2
phase 3
1
catalysts ytd
5
approvals ytd
5
recalls ytd
0
Pipeline(5)
pipeline depth5 products
1Phase 11Phase 21Phase 32Marketed
Marketed
(amoxicillin + omeprazole magnesium+ rifabutin) DR
Helicobacter pylori Infections
Marketedondansetron hydrochloride CR
Chemotherapy Induced Nausea and Vomiting
5-hydroxytryptamine receptor 3A
Phase 3(clarithromycin + clofazimine + rifabutin)
Crohn's Disease (Regional Enteritis)
Phase 2opaganib
Bile Duct Cancer (Cholangiocarcinoma)
Phase 1RHB-204
Crohn's Disease (Regional Enteritis)
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia
- phase2A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma
- —Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®)
- phase3RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease
- phase3Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease
Insider activity
source: SEC Form 4open-market buys + sells
- Apr 6, 26SELLRaday Gilead· Chief Operating Officer−$2K↗
routine RSU / option mechanics (1)
- Apr 6, 26option exerciseRaday Gilead · Chief Operating Officer30,780,000 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 11m ago
Found something off?
comments(0)
5-min edit window · permanent after that